| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 04/11/2007 | CN1946718A Novel ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus |
| 04/11/2007 | CN1946714A Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors |
| 04/11/2007 | CN1946713A Chemokine receptor antagonists |
| 04/11/2007 | CN1946712A Pyrrolidine derivative |
| 04/11/2007 | CN1946711A Diastereoselective synthesis process for the preparation of imidazole compounds |
| 04/11/2007 | CN1946710A Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2-methoxy-quinoline |
| 04/11/2007 | CN1946709A Diastereoselective addition of lithiated n-methylimidazole on sulfinimines |
| 04/11/2007 | CN1946701A Tri-substituted ureas as cytokine inhibitors |
| 04/11/2007 | CN1946700A Tri-substituted ureas as cytokine inhibitors |
| 04/11/2007 | CN1946699A Pyridazinone ureas as antagonists of alpha4 integrins |
| 04/11/2007 | CN1946695A 2-pyridinylcycloalkylcarboxamide derivatives useful as fungicides |
| 04/11/2007 | CN1946691A Novel compounds as inhibitors of hepatitis C virus NS3 serine protease |
| 04/11/2007 | CN1946685A Azetidine glycine transporter inhibitors |
| 04/11/2007 | CN1946402A Piperdine derivatives useful as CCR3 antagonists |
| 04/11/2007 | CN1946397A Ion channel modulators |
| 04/11/2007 | CN1944426A Pyridine derivative compound and its preparing method |
| 04/11/2007 | CN1944425A High effective simultanuous clean extraction of high purity solanesol and nicotine |
| 04/11/2007 | CN1944413A Pesticidal 5- (acylamino) pyrazole derivatives |
| 04/11/2007 | CN1944406A Indole heterocyclic compounds and intermediate, and synthetic method |
| 04/11/2007 | CN1944404A Indolyl alkyl-amine compounds and their preparing method and use in medicine production |
| 04/11/2007 | CN1309720C Piperazine compounds |
| 04/11/2007 | CN1309719C Derivative of phenylamide pyrimidine and application thereof |
| 04/11/2007 | CN1309710C Pyrimidine derivitive |
| 04/11/2007 | CN1309704C Anthranyl amides and their use as medicaments |
| 04/11/2007 | CN1309388C Treatment of inflammatory disorders |
| 04/10/2007 | USRE39558 For prophylaxis and therapy of obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease and prostatic disease |
| 04/10/2007 | US7202381 Compounds as opioid receptor modulators |
| 04/10/2007 | US7202368 Process for the preparation of 4-(benzimidazolymethylamino) benzamidines |
| 04/10/2007 | US7202362 Transition metal complexes from solid state synthesis |
| 04/10/2007 | US7202279 Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders |
| 04/10/2007 | US7202266 PPAR active compounds |
| 04/10/2007 | US7202263 [2-(Benzodioxo-5-ylalkylamino)ethoxy]-imidazol-1-yl-benzene derivatives, e.g., N-[2-(4-(imidazol-1-yl)phenoxy)ethyl]-N-[(1,3-benzodioxol-5-yl)methyl]amine; treating congestive heart failure |
| 04/10/2007 | US7202259 For prophylaxis and therapy of pain or diarrhea in an animal |
| 04/10/2007 | US7202257 Ureas 1-substituted with a 5 member nitrogen-containing ring in turn substituted with an oxymethylphenyl group and 3-(hetero)aryl-substituted, e.g., 1-{3-tert-butyl-1-[3-(hydroxymethyl)phenyl]-1H-pyrazol-5-yl}-3-(naphthalen-1-yl)urea; used to modulate of the activation state of p38 kinase protein |
| 04/10/2007 | US7202254 N-(p-(substituted 1,2,3-triazol-1-yl)phenyl) derivatives of cycloazaalkanes; particularly useful for treating methicillin-resistant Staphylococcus aureas infections |
| 04/10/2007 | US7202250 2-substituted, especially 2-amino-substituted, e.g., [N-(1-ethyl)propyl]-5-(2,4-dimethoxyphenyl)-3,6-dimethylpyrazine-2-amine; bind with high affinity and high selectivity to CRF1 receptors and are used to treat central nervous system disorders |
| 04/10/2007 | US7202248 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 04/10/2007 | US7202244 Chk-1 inhibitors |
| 04/10/2007 | US7202237 Pyridylether derivatives, their preparation and use |
| 04/10/2007 | CA2407100C 1-aroyl-piperidinyl benzamidines |
| 04/10/2007 | CA2270469C Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
| 04/10/2007 | CA2212895C Benzylpiperidines and piperazines as muscarinic antagonists |
| 04/10/2007 | CA2204200C Phenyl alkyl ketone substituted by cyclic amine and a process for the preparation thereof |
| 04/10/2007 | CA2164276C New highly selective process for the preparation of enantiomerically pure phenylsubstituted 1,4-dihydropyridine-3,5-dicarboxylic acid derivatives |
| 04/10/2007 | CA2159418C Stabilization of pigmented fiber with a synergistic mixture of hindered amine and uv absorber |
| 04/05/2007 | WO2007038138A2 Amido compounds and their use as pharmaceuticals |
| 04/05/2007 | WO2007038045A1 Tetrahydro-indazolyl cannabinoid modulators |
| 04/05/2007 | WO2007038036A1 Hexahydro-cycloheptapyrazole cannabinoid modulators |
| 04/05/2007 | WO2007037543A1 Biarylamide derivative |
| 04/05/2007 | WO2007037534A1 2-heteroaryl-substituted indole derivative |
| 04/05/2007 | WO2007037513A1 Aryl-substituted nitrogen-containing heterocyclic compound |
| 04/05/2007 | WO2007037187A1 Sulfonamide derivative having pgd2 receptor antagonistic activity |
| 04/05/2007 | WO2007036718A2 Compounds which have activity at m1 receptor and their uses in medicine |
| 04/05/2007 | WO2007036717A1 4- (4-BROMO-2-FLUOROANILINO) -6-METHOXY-7- (l-METHYLPIPERIDIN-4 -YLMETHOXY) QUINAZOLINE MONOHYDRATE |
| 04/05/2007 | WO2007036713A2 Chemical process |
| 04/05/2007 | WO2007036711A1 BENZIMIDAZOLONES WHICH HAVE ACTIVITY AT Ml RECEPTOR |
| 04/05/2007 | WO2007036630A1 Novel benzimidazole and benzothiazole derivatives, method for preparing same, use thereof as drugs, pharmaceutical compositions and novel use in particular as c-met inhibitors |
| 04/05/2007 | WO2007036533A2 Selected cgrp antagonists, a method for the production thereof and use in the form of drugs |
| 04/05/2007 | WO2007036532A2 Selected cgrp antagonists, methods for the production thereof and their use as medicaments |
| 04/05/2007 | WO2007036477A1 2-substituted hydroxylaminopyrimidine, method for the production and the use thereof in the form of pesticides |
| 04/05/2007 | WO2007036131A1 Carzole sulphamide derivatives and their preparation method |
| 04/05/2007 | WO2007036083A1 Indolyl acrylic derivatives and usage in preparation of immunosuppressive agent thereof |
| 04/05/2007 | WO2007006922A3 Novel 1h-indole-pyridinecarboxamide derivatives and 1h-indole-piperidinecarboxamide and their use as hydroxylase tyrosine inducers |
| 04/05/2007 | WO2006138744A3 Heteroaryl derivatives for treating viruses |
| 04/05/2007 | WO2006105304A3 Phenyl and pyridyl lta4h modulators |
| 04/05/2007 | WO2006078554A3 Cgrp receptor antagonists |
| 04/05/2007 | WO2006058338A3 4 - piperidinecarboxamide derivatives as modulators of vanilloid vr1 receptor |
| 04/05/2007 | US20070078166 Novel crystalline forms of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1h-[1,2,3] triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone |
| 04/05/2007 | US20070078164 Hypotensive agents; cardiovascular disorders; anxiolytic agents; cognition activators; diabetic neuropathy; congestive heart failure; cardiomyopathy; kidney disease; Alzheimer's disease; vision defects |
| 04/05/2007 | US20070078161 Crystalline forms of (+)- and (-) erythro-mefloquine hydrochloride |
| 04/05/2007 | US20070078154 Quinoline potassium channel inhibitors |
| 04/05/2007 | US20070078152 Piperidine derivatives |
| 04/05/2007 | US20070078139 Phosphodiesterase 4 inhibitors |
| 04/05/2007 | US20070078120 Novel piperidine derivative |
| 04/05/2007 | CA2745829A1 Chemical process |
| 04/05/2007 | CA2624162A1 Aryl-substituted nitrogen-containing heterocyclic compound |
| 04/05/2007 | CA2623958A1 2-heteroaryl-substituted indole derivative |
| 04/05/2007 | CA2623745A1 Hexahydro-cycloheptapyrazole cannabinoid modulators |
| 04/05/2007 | CA2623646A1 4- (4-bromo-2-fluoroanilino) -6-methoxy-7- (1-methylpiperidin-4 -ylmethoxy) quinazoline monohydrate |
| 04/05/2007 | CA2623525A1 Tetrahydro-indazolyl cannabinoid modulators |
| 04/05/2007 | CA2623156A1 Selected cgrp antagonists, methods for the production thereof and their use as medicaments |
| 04/05/2007 | CA2623034A1 Carboxyamine compounds and their use in the treatment of hdac dependent diseases |
| 04/05/2007 | CA2621967A1 2-substituted hydroxylaminopyrimidine, method for the production and the use thereof in the form of pesticides |
| 04/05/2007 | CA2621310A1 Sulfonamide derivative having pgd2 receptor antagonistic activity |
| 04/05/2007 | CA2621255A1 Amido compounds and their use as pharmaceuticals |
| 04/05/2007 | CA2620857A1 Novel benzimidazole and benzothiazole derivatives, method for preparing same, use thereof as drugs, pharmaceutical compositions and novel use in particular as c-met inhibitors |
| 04/05/2007 | CA2607583A1 Pantoprazole free acid form iii |
| 04/04/2007 | EP1770087A1 Selected CGRP antagonists, process for their preparation as well as their use as medicaments |
| 04/04/2007 | EP1770086A1 Selected CGRP antagonists, process for their preparation as well as their use as medicaments |
| 04/04/2007 | EP1768978A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 04/04/2007 | EP1768977A2 Compounds useful for inhibiting chk1 |
| 04/04/2007 | EP1768976A1 Crystal forms of (3r)-1-(2-methylalanyl-d-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide |
| 04/04/2007 | EP1768975A2 Pyridyl piperazines for the treatment of cns disorders |
| 04/04/2007 | EP1768974A1 Substituted diketopiperazines as oxytocin antagonists |
| 04/04/2007 | EP1768973A1 Substituted quinolones |
| 04/04/2007 | EP1768972A1 2-substituted pyrimidines, method for their production and their use for controlling pathogenic fungi |
| 04/04/2007 | EP1768959A2 Hetero isonipecotic modulators of vanilloid vr1 receptor |
| 04/04/2007 | EP1768957A2 Indole-2-carboxylic acid hydrazides as glycogen phosphorylase inhibitors |
| 04/04/2007 | EP1768956A1 Amide derivatives as inhibitors of histone deacetylase |
| 04/04/2007 | EP1768667A1 Cannabinoid receptor ligands |